Battling Infection: Hospitals Seek High-Tech Solutions
Executive Summary
The market for diagnostic and infection control products will see continued growth as hospitals and other providers look to the technology sector to help fight the battle against health care-associated infections and antibiotic-resistant organisms.
You may also be interested in...
Exec Chat: M Holland's Josh Blackmore On Plastics' Hard Impact On Medtech Innovation
Josh Blackmore recently joined M Holland Co., a leading distributor of thermoplastic resin, as its global healthcare manager to help expand the company's participation in the medical device industry. He provides insight on the importance of plastics and how this material plays an important role in helping to drive medical device-makers innovate.
Immunexpress Aims To Leverage Anti-Infection Incentives For Sepsis Diagnostic
Immunexpress' SeptiCyte system is designed to directly quantify molecular markers of sepsis from patient blood samples and within a few hours detect the probability that a patient has sepsis, allowing for aggressive treatment, or if the test result is negative, preventing unnecessary antibiotics.
Immunexpress Looks To Leverage U.S. Anti-Infection Incentives With Unique Sepsis Diagnostic
The Seattle company's SeptiCyte system is designed to directly quantify molecular markers of sepsis from patient blood samples and tell doctors the probability that a patient has sepsis within four hours, allowing for aggressive treatment of sepsis or, if the test result is negative, preventing unnecessary antibiotics.